Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The effect of neuromuscular blocking agents (NMBA, e.g. rocuronium) on respiratory muscle
activity is well known. However, since the availability of sugammadex, to our knowledge, no
study has been conducted to evaluate the effect of this novel product on these muscles.
Our hypothesis is that by applying a different strategy in the use of neuromuscular blocking
agents and their reversal agents we might see a different activity of the respiratory
muscles.